European Cardiac Ablation Market size is estimated to surpass USD 2.5 billion by 2028, according to a latest forecast report by Graphical Research.
Growing geriatric population coupled with the development of advanced cardiac ablation devices for the disease treatment will contribute to the market growth. Elderly population is more vulnerable to cardiovascular diseases, that will lead to increased number of treatment procedures. According to the World Health Organization, the number of individuals aged 85 years and older is estimated to reach nearly 40 million by 2050 in the Europe. Aging causes several changes in the heart and blood vessels, thus increasing the risk of cardiac disorders. Thus, as cardiac ablation is proven, safe and effective treatment for irregular heart rhythm, the number of procedures will increase tremendously with growing elderly pool. Along with the disease burden, product developments catering to increasing patient population will contribute to the industry demand.
Adoption of advanced technologies in cardiac procedures with its increasing availability and accessibility in emerging countries is expected to offer unprecedented industry growth opportunities. The developing nations have recorded a continuous growth in the number of surgical procedures due to the expanding target patient population. Additionally, product advancements have enhanced the safety and efficiency of atrial fibrillation treatments, thereby stimulating the product demand with increased procedural volume. Moreover, business expansion by the leading companies in the region.
The electrical ablators segment held over 9% market share in 2021 attributed to the high success rate in treatment of arrhythmic heart conditions and reduced procedural time. According to the data published by National Health Service, in 2019, more than 2 million individuals in the UK were suffering from arrhythmias. Thus, the treatment application of electrical ablators in patients with arrhythmia will offer immense growth opportunities with rising disease incidence rate in the region.
The open/surgical segment accounted over USD 250 million revenue in 2021. The segment is forecasted to progress at significant rate with higher prevalence of atrial fibrillation as the procedure aims to eliminate the atrial fibrillation. Furthermore, introduction of advanced devices to reduce procedural complications and minimize treatment complexity will augment the market growth.
Browse detailed statistical insights from the report, “Europe Cardiac Ablation Market Forecast 2028 By Application (Atrial Fibrillation & Flutter, Tachycardia), By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), By Approach (Catheter-based, Open/Surgical), By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Research Report, Country Outlook (Germany, UK, France, Italy, Spain, Russia, Ukraine, Poland, Switzerland, Belgium, Greece, Czech Republic, The Netherlands, Sweden), COVID-19 Impact Statistics, Country Outlook, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The tachycardia segment will grow at 15.5% CAGR during the forecasted timeframe. High consumption of alcohol, increased levels of caffeine, fluctuating blood pressure, and substance imbalance in the blood are some of the causes contributing to the existing disease burden. To cater increasing incidence of tachycardia, healthcare organizations are adopting advanced technologies and are increasingly focusing on development of suitable infrastructure. This will enable greater treatment accessibility, thereby stimulating the product demand.
The cardiac centers segment will exhibit a CAGR of 15.2% during the analysis timeframe credited to increasing funding to expand facility network providing specialty treatments for cardiovascular diseases. Availability of highly skilled workforce, specialists and developed infrastructure to provide advanced treatments have resulted in preference for these facilities. Further, these centers offer broad range of invasive as well as non-invasive treatments that will positively impact the product sales. Thus, facility expansion, patient preference and availability of resources to cater demand for advanced treatments will boost the market expansion.
UK cardiac ablation industry observe around 14.4% growth rate through 2028 owing to increasing demand for minimally invasive procedures coupled with growing healthcare expenditure in the country. For instance, as per the Office for National Statistics, healthcare spending in the UK was valued over USD 300 billion in 2020. Rising spending will increase the treatment affordability, thereby benefiting the product demand. Further, incidence of obesity and adoption of unhealthy lifestyle will contribute to the existing disease burden. Thus, along with disease prevalence, improved access to advanced ablation technologies in the country.
The European cardiac ablation market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:
Europe Market, By Product
- Radiofrequency (RF) Ablators
- Electrical Ablators
- Cryoablation Devices
- Ultrasound Ablators
Europe Market, By Approach
Europe Market, By Application
- Atrial Fibrillation & Flutter
Europe Market, By End-use
- Ambulatory Surgical Centers
- Cardiac Centers
The above information has been provided for the following countries:
- Czech Republic